Advertise With Us
Biotech/Biomedical Advertising Programs
All Channels
AI Agent
Airborne
Audience
Audio
Augmented Reality (AR)
Billboard
Cable TV
Cinema
CTV/OTT
Digital Out of Home
E-Newsletter
Email Broadcast
Event
Fax Broadcast
Free Standing Insert
Furniture
Kiosk
Magazine
Metaverse / VR
Mobile Display
Native
Newspaper
Online Display
Other
Podcast
Point of Sale
Postal
Radio
Search
SMS
Social
Television
Transit
Video
Name
- (Reach)
Vendor
Channels
Last Updated
U.S. Pharmacist - Pharmacist Resource for Clinical Excellence
- 163,700
Jobson Healthcare Information LLC
5 days ago
Lambert-Eaton News
Bionews, Inc.
19 days ago
Hypoparathyroidism News
Bionews, Inc.
19 days ago
Huntington’s Disease News
Bionews, Inc.
19 days ago
Hemophilia News Today
Bionews, Inc.
19 days ago
Friedreich’s Ataxia News
Bionews, Inc.
19 days ago
Fragile X News Today
Bionews, Inc.
19 days ago
Amyloidosis News Today
Bionews, Inc.
19 days ago
Fabry Disease News
Bionews, Inc.
20 days ago
Epidermolysis Bullosa News
Bionews, Inc.
20 days ago
Ehlers-Danlos News
Bionews, Inc.
20 days ago
Dravet Syndrome News
Bionews, Inc.
20 days ago
Cystic Fibrosis News Today
Bionews, Inc.
20 days ago
Cushing’s Disease News
Bionews, Inc.
20 days ago
COPD News Today
Bionews, Inc.
20 days ago
SMA News Today
Bionews, Inc.
20 days ago
Cold Agglutinin Disease News
Bionews, Inc.
20 days ago
Sjögren’s Syndrome News
Bionews, Inc.
20 days ago
Sickle Cell Disease News
Bionews, Inc.
20 days ago
Scleroderma News
Bionews, Inc.
20 days ago
Sarcoidosis News
Bionews, Inc.
20 days ago
Sanfilippo News
Bionews, Inc.
20 days ago
Charcot-Marie-Tooth News
Bionews, Inc.
20 days ago
Rett Syndrome News
Bionews, Inc.
20 days ago
ANCA Vasculitis News
Bionews, Inc.
20 days ago
Angelman Syndrome News
Bionews, Inc.
20 days ago
Pulmonary Hypertension News
Bionews, Inc.
20 days ago
Alzheimer’s News Today
Bionews, Inc.
20 days ago
AADC News
Bionews, Inc.
20 days ago
Pulmonary Fibrosis News
Bionews, Inc.
20 days ago
No Programs Found
© Copyright 2013-2022 NextMark, Inc.
d/b/a
Bionic Advertising Systems.
All Rights Reserved.
Terms of Use.